Document is current
Any future updates will be listed below
-
Authors
Anand, Vivek
Oderinde, Bolutyfe
Siddiqui, Maryam
Tyagi, Anudishi
Borgman, Jenny
Wu, Chong
Andreeff, Michael
Battula, V. Lokesh
-
Funding
Funding for this research was provided by:
Breast Cancer Research Foundation (00000313)
Y-mAbs Therapeutics
National Institutes of Health (P30 CA016672)
- License Information
-
More Information
Article History
Received: 24 April 2025
Accepted: 9 October 2025
First Online: 5 November 2025
Competing interests
: Authors V.L.B. and M.A. hold US Patent Number US 9846160 B2, titled “Ganglioside GD2 as a marker and target on cancer stem cells.” The authors declare no other Competing Financial or Non-Financial Interests.
